On July 13, 2024, the Vĩnh Long Convention Center, in collaboration with Cuu Long Pharmaceuticals Corporation (DCL), co-hosted the 4th Vietnam-US International Neuroscience Conference. Organized by the Vĩnh Long Department of Health, the conference centered on “Updates in Diagnosis and Treatment of Stroke, Pain, Neurological Disorders, and Related Neurological Diseases.”
The 2024 Vietnam-US International Neuroscience Conference drew nearly 1,000 delegates, featuring over 60 presentations and medical sessions by domestic and international scientists and experts. These sessions aimed to share new information and achievements in science with experienced clinical and paraclinical specialists across emergency, diagnostic, and therapeutic specialties in neurology, as well as other medical fields globally and regionally, to further enhance the quality of healthcare.
At the conference, Ms. Nguyen Thi Quyen Thanh, Vice Chairwoman of the People’s Committee of Vĩnh Long Province, stated, “This conference is seen as a breakthrough development direction for the healthcare sector, providing a valuable opportunity for doctors, nurses, and healthcare workers in Vĩnh Long province and other regional localities to update their knowledge and directly exchange professional expertise.”
The overall view of the 4th Vietnam-US International Neuroscience Conference in 2024.
Known as one of Vietnam’s leading pharmaceutical companies with nearly 50 years of experience, DCL has continually improved product quality, launching various health protection and support products that meet the stringent requirements of consumers, partners, and leading experts in the Pharmaceuticals and Healthcare fields.
At the 2024 Vietnam-US International Neuroscience Conference, DCL aimed to showcase its brand and products while enhancing its credibility and recognition among medical professionals, experts, partners, and customers. DCL featured a booth displaying key products like Panalgan, Calfizz, Cefixim 200, and empty capsules. “DCL’s pharmaceutical products, medical devices, and empty capsules all meet high standards and are regularly trusted by hospitals, partners, and customers,” noted a delegate at the conference.
The delegates at the conference highly regarded the products of DCL.
Conference participants highly regarded DCL’s products. Besides product development and infrastructure investment, the company also focuses on community activities. “With a mission to connect and improve community life through optimal health solutions, DCL is committed to supporting scientific activities in healthcare and free medical treatment programs to enhance the lives of the Vietnamese people,” shared Mr. Tran Anh Kiet, Director of DCL’s Vĩnh Long branch, at the conference.
Over the years, DCL has intensified efforts to connect and collaborate with domestic and international businesses and experts to enhance production capabilities, expand, and develop products to meet the growing demands of the market, partners, and consumers, aiming to realize its vision of becoming the most highly regarded pharmaceutical company in Vietnam by patients, partners, and staff through innovative, accessible, and high-quality products and services.
